You are here:

Siponimod for secondary progressive MS: help us make the case to NICE

Published on

NICE is assessing siponimod for secondary progressive MS (SPMS) to decide whether it should be prescribed by the NHS in England and Wales.  Scotland and Northern Ireland will carry out separate appraisals.

The MS Trust will be explaining to NICE why we think siponimod should be made available on the NHS. To help us make a strong case, we want to hear your experiences of living with SPMS, your views on current NHS care for SPMS and your thoughts on siponimod.

We’d like to hear from you if you live in the UK and

  • you have secondary progressive MS
  • you have a different type of MS, but would like to add your views
  • you are a partner / friend / relative / carer of someone with SPMS
  • you are a health professional providing care for people with SPMS

Tell us what you think by completing this short questionnaire by 17 September.

Find out more

David's Diary- Should we all be saying yes to the Covid 19 vaccine?

David's Diary- Should we all be saying yes to the Covid 19 vaccine?

18 Feb 2021 - 00:00

For the last few weeks our Enquiry Service at the MS Trust has been busy with questions about the vaccination. In his latest blog piece for the MS Trust, CEO David Martin asks the question, 'Should we all be saying yes to the Covid 19 vaccine?'

Monkey sox are back!

Monkey sox are back!

17 Feb 2021 - 00:00

...but this time they've gone casual! We are very excited to have partnered once again with Monkey Sox to bring you an exclusive MS Trust design.

Print this page